DENVER, CO–UBQU, (Marketwired – Feb 23, 2016) – Ubiquitech Software Corp. (www.ubiquitechsoftware.com) (OTC PINK: UBQU), an International Technology and Services company that owns the division HempLife Today™ (www.hemplife.com), is announcing year over year revenue growth in excess of 300% for 2015. The Company reported revenues of $3,049,465 for the year ended November 30, 2015 versus revenues of $929,499 for the same period in 2014.
“We are excited to have met our internal revenue projections for the fiscal year 2015,” said Tim Zorn, CEO of HempLifeToday. “And our growth plans are on track as we move through 2016. We are proud to be an industry leader and look forward to continuing to establish the company as an innovator in the CBD marketplace.”
During 2015, HempLife Today™ continued its expansion in the growing CBD oil industry. As the leader in online sales of CBD Oil derived from Hemp, the Company continues to bring new products to market under its proprietary brand of CannazALL™ CBD products. This includes its popular Tinctures, Oils, Vape Oils, new Capsules, and Combo Packs, as well as new products to be launched during 2016. HempLife Today™ continues to add new loyal customers as it expands its presence and message through its newly launched affiliate partner program.
About Ubiquitech Software Corp.
Ubiquitech Software Corp., through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday.com™.
HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed four CannazALL™ CBD oil products that include its popular CBD Tincture, Oil, Capsules and e-liquid.
This press release contains forward-looking statements. Words such as “expects”, “intends”, “believes”, and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company’s filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.